NTN21277

Non Chimik:

(2S,4R)-1-((S)-2-(3-(2-((5-((4-((3-chloro-4-fluorophenyl)amino))-7-methoxyquinazolin-6-yl)) oxy)pentyl)oxy)eth oxy)propanamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide

Kòd SMILES:

O=C([C@H]1N(C([C@@H]](NC(CCOCCOCCCCCOC2=CC3=C(NC4=CC=C(F))C(Cl)=C4)N=CN=C3C=C2OC )=O)C(C)(C)C)=O)C[C@H](O)C1)NCC5=CC=C(C6=C(C)N=CS6)C=C5

Kòd InChi:

InChI=1S/C47H57ClFN7O8S/c1-29-42(65-28-53-29)31-11-9-30(10-12-31)25-50-45(59)38-22-3 3(57)26-56(38)46(60)43(47(2,3)4)55-41(58)15-18-63-20-19-62-16-7-6-8- 17-64-40-23-34-37 (24-39(40)61-5)51-27-52-44(34)54-32-13-14-36(49)35(48)21-32/h9-14,21,23-24 ,27-28,33,3 8,43,57H,6-8,15-20,22,25-26H2,1-5H3,(H,50,59)(H,55,58)(H,51,52,54)/t33- ,38+,43-/m1/s1

InChi kle:

NICKHWYZMNLEPJ-TZSMONEZSA-N

Mot:

PROTAC 3 ki baze sou Gefitinib; NTN21277; NTN-21277; NTN 21277

Solibilite: 

Depo: 

Deskripsyon:

NTN21277, ke yo rele tou Gefitinib ki baze sou PROTAC 3 se yon PROTAC VHL-rekritman ki pwovoke degradasyon nan EGFR ak EGFR mutan ak DC50 nan 11.7 nM ak 22.3 nM pou selil HCC827 (Exon 19 del) ak selil H3255 (L858R).

Sib: EGFR